HomeCompareMCK vs NEM

MCK vs NEM: Dividend Comparison 2026

MCK yields 0.38% · NEM yields 0.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCK wins by $23.4K in total portfolio value· pulled ahead in Year 3
10 years
MCK
MCK
● Live price
0.38%
Share price
$860.19
Annual div
$3.28
5Y div CAGR
66.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.3K
Annual income
$10,761.37
Full MCK calculator →
NEM
NEM
● Live price
0.98%
Share price
$103.12
Annual div
$1.01
5Y div CAGR
-3.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$71.65
Full NEM calculator →

Portfolio growth — MCK vs NEM

📍 MCK pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCKNEM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCK + NEM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCK pays
NEM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCK
Annual income on $10K today (after 15% tax)
$32.41/yr
After 10yr DRIP, annual income (after tax)
$9,147.16/yr
NEM
Annual income on $10K today (after 15% tax)
$83.25/yr
After 10yr DRIP, annual income (after tax)
$60.90/yr
At 15% tax rate, MCK beats the other by $9,086.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCK + NEM for your $10,000?

MCK: 50%NEM: 50%
100% NEM50/50100% MCK
Portfolio after 10yr
$32.5K
Annual income
$5,416.51/yr
Blended yield
16.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NEM right now

MCK
Analyst Ratings
1
Strong
24
Buy
6
Hold
Consensus: Buy
Price Target
$982.38
+14.2% upside vs current
Range: $900.00 — $1,085.00
Altman Z
5.9
Piotroski
7/9
NEM
Analyst Ratings
27
Buy
9
Hold
Consensus: Buy
Price Target
$137.37
+33.2% upside vs current
Range: $97.00 — $177.00
Altman Z
4.2
Piotroski
9/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCK buys
0
NEM buys
0
No recent congressional trades found for MCK or NEM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCKNEM
Forward yield0.38%0.98%
Annual dividend / share$3.28$1.01
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR66.7%-3.6%
Portfolio after 10y$44.3K$20.8K
Annual income after 10y$10,761.37$71.65
Total dividends collected$22.6K$829.00
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyBuy
Analyst price target$982.38$137.37

Year-by-year: MCK vs NEM ($10,000, DRIP)

YearMCK PortfolioMCK Income/yrNEM PortfolioNEM Income/yrGap
1$10,764$63.56$10,794$94.42$30.00NEM
2$11,624$106.59$11,642$91.82$18.00NEM
3← crossover$12,617$179.33$12,546$89.22+$71.00MCK
4$13,803$303.26$13,511$86.62+$292.00MCK
5$15,286$516.89$14,541$84.04+$745.00MCK
6$17,248$891.81$15,640$81.49+$1.6KMCK
7$20,023$1,567.70$16,814$78.97+$3.2KMCK
8$24,260$2,835.35$18,067$76.48+$6.2KMCK
9$31,310$5,352.05$19,406$74.04+$11.9KMCK
10$44,263$10,761.37$20,836$71.65+$23.4KMCK

MCK vs NEM: Complete Analysis 2026

MCKHealthcare

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Full MCK Calculator →

NEMMaterials

Newmont Corporation engages in the production and exploration of gold. It also explores for copper, silver, zinc, and lead. The company has operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. As of December 31, 2021, it had proven and probable gold reserves of 92.8 million ounces and land position of 62,800 square kilometers. The company was founded in 1916 and is headquartered in Denver, Colorado.

Full NEM Calculator →
📬

Get this MCK vs NEM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCK vs SCHDMCK vs JEPIMCK vs OMCK vs KOMCK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.